Sort   by:  
 Page size 
UnknownCD40L-armed oncolytic herpes simplex virus suppresses pancreatic ductal adenocarcinoma by facilitating the tumor microenvironment favorable to cytotoxic T cell response in the syngeneic mouse model.
Not available
S-EPMC8796271 | biostudies-literature
UnknownThe crystal structure of coronavirus RBD-TMPRSS2 complex provides basis for the discovery of therapeutic antibodies.
Not available
S-EPMC12274457 | biostudies-literature
UnknownFirst-in-human phase I study of CLL-1 CAR-T cells in adults with relapsed/refractory acute myeloid leukemia.
Not available
S-EPMC9264641 | biostudies-literature
UnknownChimeras co-targeting antigens and FcγRIIb trigger degradation of extracellular soluble proteins and pathological aggregates.
Not available
S-EPMC12804944 | biostudies-literature
UnknownMolecular deconvolution of the neutralizing antibodies induced by an inactivated SARS-CoV-2 virus vaccine.
Not available
S-EPMC8080482 | biostudies-literature
UnknownOncolytic virus-induced IL-1β<sup>+</sup> monocyte-IL-6<sup>+</sup> CAF axis suppresses dendritic cell-mediated antitumor immunity in pancreatic cancer.
Not available
S-EPMC12636881 | biostudies-literature
UnknownReduction of circulating IgE and allergens by a pH-sensitive antibody with enhanced FcγRIIb binding.
Not available
S-EPMC11489548 | biostudies-literature
UnknownSingle-cell data-driven design of armed oncolytic virus to boost cooperative innate-adaptive immunity against cancer.
Not available
S-EPMC11852947 | biostudies-literature
UnknownReshaping the Immune Microenvironment by Oncolytic Herpes Simplex Virus in Murine Pancreatic Ductal Adenocarcinoma.
Not available
S-EPMC7854309 | biostudies-literature
UnknownVirus envelope glycoprotein targeting bispecific T cell engager protects mice from lethal severe fever with thrombocytopenia virus infection.
Not available
S-EPMC12711666 | biostudies-literature
Sort   by:  
 Page size